Related Experiment Video
Updated: Sep 27, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
LINC00240 knockdown inhibits nasopharyngeal carcinoma progress by targeting miR-26a-5p
Xing Chen1, Guixiang Wu2, Jing Qing1
1Department of Otorhinolaryngology, Ningbo First Hospital, Ningbo City, China.
Objective:
This study intended to explore the regulatory functions of LINC00240 on nasopharyngeal carcinoma (NPC).
Methods:
MiR-26a-5p inhibitor, mimic, and siLINC00240 were transfected into NPC cells. QRT-PCR was employed to assess miR-26a-5p and LINC00240 expressions. The targeting relationship of LINC00240 and miR-26a-5p was analyzed through dual luciferase reporter and RNA immunoprecipitation assay. Cell counting kit-8 assay, colony formation assay, flow cytometry assay, wound healing assay, Transwell assay and in vitro angiogenesis assay were adopted for the evaluation of the effects of LINC00240 or miR-26a-5p and LINC00240 on NPC cells regarding cell proliferation, apoptosis and cycle, migration, invasion, and angiogenesis. EZH2, cell cycle, and epithelial-mesenchymal transition (EMT)-related protein expression was tested through Western blot.
Results:
LINC00240 had a high expression in NPC tissues and cell lines. Silenced LINC00240 significantly suppressed the 5-8F and HK1 cell proliferation, invasion, migration, and angiogenesis, but raised cell apoptosis, and cells were blocked in G0/G1 phase. MiR-26a-5p was a target of LINC00240. MiR-26a-5p upregulation suppressed the NPC cell proliferation, migration, invasion, angiogenesis, N-cadherin and EZH2 expression, while it elevated apoptosis and p21, p27 and E-cadherin expressions, whereas miR-26a-5p downregulation performed conversely. LINC00240 knockdown partially offset the effects of miR-26a-5p downregulation on cell proliferation, migration, invasion, angiogenesis, apoptosis, and EZH2.
Conclusion:
LINC00240 knockdown restrained cell proliferation, invasion, migration, and angiogenesis, while it advanced apoptosis via miR-26a-5p in NPC by EZH2 inhibition.
Insights
Long non-coding RNA LINC00240 promotes nasopharyngeal carcinoma (NPC) progression by inhibiting miR-26a-5p and EZH2. Silencing LINC00240 restrains NPC cell proliferation, invasion, and angiogenesis, while promoting apoptosis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Nasopharyngeal carcinoma (NPC) is a prevalent head and neck cancer.
- Long non-coding RNAs (lncRNAs) play critical roles in tumorigenesis.
- The specific role of LINC00240 in NPC remains to be fully elucidated.
Purpose of the Study:
- To investigate the regulatory function of LINC00240 in nasopharyngeal carcinoma (NPC).
- To explore the molecular mechanism underlying LINC00240's role in NPC progression.
Main Methods:
- LINC00240 and miR-26a-5p expression analyzed using qRT-PCR.
- Interaction between LINC00240 and miR-26a-5p confirmed via dual luciferase reporter and RNA immunoprecipitation assays.
- NPC cell proliferation, apoptosis, cell cycle, migration, invasion, and angiogenesis were assessed using various in vitro assays.
- Protein expression related to cell cycle and epithelial-mesenchymal transition (EMT) was evaluated by Western blot.
Main Results:
- LINC00240 was highly expressed in NPC tissues and cell lines.
- Silencing LINC00240 suppressed NPC cell proliferation, invasion, migration, and angiogenesis, while increasing apoptosis and inducing G0/G1 cell cycle arrest.
- LINC00240 directly targeted and regulated miR-26a-5p.
- Upregulation of miR-26a-5p inhibited NPC cell proliferation, migration, invasion, and angiogenesis, and decreased N-cadherin and EZH2 expression, while promoting apoptosis and increasing p21, p27, and E-cadherin expression.
Conclusions:
- LINC00240 knockdown inhibits NPC cell proliferation, invasion, migration, and angiogenesis by upregulating miR-26a-5p and inhibiting EZH2.
- LINC00240 acts as an oncogenic lncRNA in NPC through the miR-26a-5p/EZH2 axis.
Related Concept Videos
MicroRNAs
Experimental RNAi
lncRNA - Long Non-coding RNAs

